The present invention relates to new bisbenzisoselenazolonyl derivatives
of the following general formulae (I), (II) or (III) and their
pharmaceutically acceptable salts. The inventive derivatives have
antineoplastic, anti-inflammatory and antithrombotic activities
##STR00001##